Preventive Breast Cancer Medicine Now No Cost For Many at High Risk
The Department of Health and Human Services (HHS) recently lessened the financial load for those at high risk for developing breast cancer after information was released from an independent panel of experts. The specialized group called United States Preventative Services Task Force recommended that health care providers prescribe preventive medicine to those with an increase risk of developing the disease. Recently, the HHS issued new guidance to follow under the Affordable Care Act stating that most health insurance providers and employers will have to cover raloxifene and tamoxifen, which are two of the leading preventative medications for breast cancer.
Most women who have been told by health care providers that they have a high risk for developing breast cancer can obtain the necessary pharmaceuticals without having to pay out-of-pocket expenses. These medications have been shown to significantly reduce the risk of certain types of the disease.
“We are making significant advancements in combating this disease – and for women who are shown to be at a higher relative risk for breast cancer, today, access to early treatments can improve their health,” Kathleen Sebelius, HHS secretary, said in a blog post.